Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6-23 months over multiple seasons

Vaccine

Volumn 31, Issue 29, 2013, Pages 2974-2978

  Shen, Shixin ^a   Campitelli, Michael A ^d   Calzavara, Andrew ^d   Guttmann, Astrid ^b,d,g   Kwong, Jeffrey C ^a,c,d,e,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Ambulatory care; Human influenza vaccines; Infant; Influenza; Premature

Indexed keywords

INFLUENZA VACCINE;

AMBULATORY CARE; ARTICLE; CANADA; CHILD; COHORT ANALYSIS; CONSULTATION; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HEALTH CARE UTILIZATION; HUMAN; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEASONAL INFLUENZA;

AMBULATORY CARE; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ONTARIO; SEASONS; VACCINATION;

EID: 84879011453     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.011     Document Type: Article

References (20)

1. Saari T.N. American Academy of Pediatrics Committee on Infectious Disease. Immunization of preterm and low birth weight infants. Pediatrics 2003, 112(1 Pt 1):193-198.
2. National Advisory Committee on Immunization An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season. Can Commun Dis Rep 2003, 29:1-20.
3. Jefferson T., Rivetti A., Harnden A., Di Pietrantonj C., Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, (2):004879.
4. Katayose M., Hosoya M., Haneda T., et al. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons. Vaccine 2011, 29(9):1844-1849.
5. Heinonen S., Silvennoinen H., Lehtinen P., Vainionpaa R., Ziegler T., Heikkinen T. Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study. Lancet Infect Dis 2011, 11(1):23-29.
6. Allison M.A., Daley M.F., Crane L.A., et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. J Pediatr 2006, 149(6):755-762.
7. Ritzwoller D.P., Bridges C.B., Shetterly S., Yamasaki K., Kolczak M., France E.K. Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 2005, 116(1):153-159.
8. Eisenberg K.W., Szilagyi P.G., Fairbrother G., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122(5):911-919.
9. Shuler C.M., Iwamoto M., Bridges C.B., et al. Vaccine effectiveness against medically attended, laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007, 119(3):e587-e595.
10. Staat M.A., Griffin M.R., Donauer S., et al. Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. Vaccine 2011, 29(48):9005-9011.
11. Treanor J.J., Talbot H.K., Ohmit S.E., et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012, 55(7):951-959.
12. Cochran L.W., Black S., Klein N.P., Dekker C.L., Lewis E., Reingold A.L. Vaccine effectiveness against laboratory-confirmed infuenza in infants: a matched case control study. Hum Vaccines 2010, 6(9):729-735.
13. Fujieda M., Maeda A., Kondo K., Kaji M., Hirota Y. Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season. Vaccine 2006, 24(7):957-963.
14. Maeda T., Shintani Y., Nakano K., Terashima K., Yamada Y. Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months. Pediatr Int 2004, 46(2):122-125.
15. Szilagyi P.G., Fairbrother G., Griffin M.R., et al. Influenza vaccine effectiveness among children 6 to 59 months of age during 2 influenza seasons: a case-cohort study. Arch Pediatr Adolesc Med 2008, 162(10):943-951.
16. D'Angio C.T., Heyne R.J., Duara S., et al. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J 2011, 30(7):570-574.
17. Sasaki Y., Kusuhara K., Saito M., et al. Serum immunoglobulin levels do not affect antibody responses to influenza HA vaccine in preterm infants. Vaccine 2006, 24(12):2208-2212.
18. Hoberman A., Greenberg D.P., Paradise J.L., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003, 290(12):1608-1616.
19. Heikkinen T., Ruuskanen O., Waris M., Ziegler T., Arola M., Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991, 145(4):445-448.
20. Moran K., Maaten S., Guttmann A., Northrup D., Kwong J.C. Influenza vaccination rates in Ontario children: implications for universal childhood vaccination policy. Vaccine 2009, 27(17):2350-2355.